Randomized Study of New Formulation Ophthalmic Cysteamine Hydrochloride for Corneal Cystine Accumulation in Patients With Cystinosis
NCT00010426
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystinosis
View Trial DetailsNCT Number: NCT00004350
OBJECTIVES:
I. Classify renal tubular defects using clinical and biochemical findings in patients with Fanconi syndrome and cystinosis.
Looking for future studies?
Notify Me0 year and older
All sexes
Observational
PROTOCOL OUTLINE:
Patients receive a clinical and biochemical evaluation, including a psychometric assessment and molecular, renal, and thyroid studies.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
National Center for Research Resources (NCRR)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00010426
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystinosis
View Trial DetailsNCT00004312
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystinosis
La Jolla, California, United States
View Trial DetailsNCT05687474
3-Hydroxy 3-Methyl Glutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency
Liège, Wallonia, Belgium
View Trial DetailsNCT01744782
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystinosis
Chicago, Illinois, United States
View Trial Details